这家成立于2018年的医疗技术公司通过其技术平台为患者提供个性化手术方案及定制化脊柱植入物。其 aprevo技术平台目前已获批用于腰椎融合手术，公司正在开发针对颈椎融合手术的解决方案，预计2026 年实现商业化。 Carlsmed的上市正值美国医疗健康类IPO融资持续低迷之际。彭博汇编数据显示，2025年迄今美国交易 所该行业新上市公司仅募集21亿美元资金，较2024年同期下降近半。 根据此前提交给美国证券交易委员会的文件，该公司原定发行价区间为每股14至16美元。按发行价计 算，总部位于加州卡尔斯巴德的Carlsmed市值达到3.977亿美元(基于申报文件披露的流通股数量)。 B Capital Group关联基金与美国风险投资合伙公司(USVP)是Carlsmed的主要机构投资者。本次发行后， 两家机构的持股比例将分别稀释至26.3%和21.2%。 联合创始人兼首席执行官Michael Cordonnier在IPO后的持股比例预计为5.9%。 智通财经APP获悉，医疗科技公司Carlsmed(CARL.US)完成1.005亿美元IPO，条款显示，这家运用人工 智能技术实现脊柱手术个性化的医疗科技公司以每股 ...

Company Overview - Carlsmed Inc. plans to raise up to $107.2 million through an IPO, with a proposed share price range of $14 to $16 for 6.7 million shares, potentially valuing the company at approximately $424.3 million [1][2] - The company specializes in personalized surgical solutions and custom spinal implants using its AI technology platform, aprevo, which is currently approved for lumbar fusion surgeries [2] Financial Performance - For the first three months of 2025, Carlsmed reported revenues of $10.2 million and a net loss of $5.7 million, compared to revenues of $5.1 million and a net loss of $5.4 million in the same period the previous year [1] Market Context - The healthcare sector's IPO financing has been sluggish, with only $2.1 billion raised by new companies in this sector in 2025, representing a decline of over 40% compared to the same period in 2024 [1] - Carlsmed's major investors include B Capital Group and US Venture Partners, holding 35.1% and 28.3% of shares respectively prior to the IPO [2] Technology Development - The company is developing a version of its aprevo platform for cervical fusion surgeries, expected to be commercially available by 2026 [2] - As of March 2025, approximately 177 surgeons have utilized the aprevo platform for surgeries, an increase from 103 surgeons in the previous year [2] IPO Details - The IPO is being led by Bank of America, Goldman Sachs, and Piper Sandler Cos., with the stock expected to trade under the ticker symbol CARL on the Nasdaq Global Select Market [2]